Right chemistry from the start

BioCat 23/09/2025

Every step of the process, from initial talks to signing the contract, was pragmatic, straightforward, and quick.

Addlife 2000 7 Linus Crop

When we began considering the future of BioCat, I realized that selling the company was about much more than just the numbers. While the financial side is important, what really mattered was finding a partner who would respect our values, support our team, and help us continue building on our strong foundation.

We had been aware of AddLife for some time, particularly through our relationship with Euroclone, which spoke very positively about joining the AddLife family. That's why we proactively reached out to AddLife. From the very first call with Peter Simonsbacka, I felt that we shared a common understanding of the distribution business in the Life Sciences and what it takes to succeed.

The chemistry was right from the start, and every step of the process, from initial talks to signing the contract, was pragmatic, straightforward, and quick.

What I appreciate most is that AddLife truly lives its values. They combine the resources, networks, and expertise of a large company with the flexibility, personality, and efficiency of an entrepreneur. This isn’t just something written on a website; it’s something you feel in every interaction, from leadership to every team member. The transition for our team was seamless, and AddLife kept their word in every respect.

Today, BioCat benefits from being part of a larger group while maintaining our individuality, agility, and entrepreneurial spirit. Support from AddLife Academy, along with exchanges between companies, provides a strong foundation for the future. I am proud to be part of AddLife, and I look forward to what we can achieve together.

Michael Hartman, former co-owner of BioCat 

News from AddLife’s subsidiaries

ETF 251104 ROPOX 2167
05 November 2025
Ropox Prize 2025

The prize recognizes remarkable efforts to strengthen and develop the occupational therapy profession and the entire area of ​​assistive devices.

Ropox
DSC 0111 BMI 2025
04 November 2025
Strong company values

Positive feedback from entrepreneurs within the AddLife family gave me the confidence to join,

Biomedica Italia